Shahed Iqbal

机构：Chittagong Medical College, Gilead Sciences (United States) · ORCID：0000-0002-3013-4750

发表论文 94 篇 · 总被引 1797 次 · h-index 24

代表论文

• Treatment outcomes for newly diagnosed, treatment-naïve TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis (2023 · Journal of Hematology & Oncology · 被引 73)
• Clinical Pharmacology Applications of Real‐World Data and Real‐World Evidence in Drug Development and Approval–An Industry Perspective (2023 · Clinical Pharmacology & Therapeutics · 被引 36)
• Clinical characteristics and overall survival among acute myeloid leukemia patients with TP53 gene mutation or chromosome 17p deletion (2023 · American Journal of Hematology · 被引 20)
• Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study (2025 · BMJ Open · 被引 19)
• Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes (2023 · Clinical Lymphoma Myeloma & Leukemia · 被引 18)
• Sociodemographic factors, biomarkers and comorbidities associated with post-acute COVID-19 sequelae in UK Biobank (2025 · Nature Communications · 被引 4)